Twin Cities-based ProEncia Biotechnology, a biopharma startup, today announced the company has closed significant pre-seed funding to advance its next-generation periodontal disease treatment. Funding ...
A recovering IPO market, surging mergers and acquisitions fuel more biotech venture deals.
A young California start-up wants to do for drug development what enterprise software did for accounting and sales: put the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results